GenIUL Now Licenced to Offer PMA for Viability PCR
It concerns the unique Sub Licensee from QIAGEN for the manufacturing and sales of Propidium Monoazide during an interim period. Nowadays GenIUL is the only company respecting the intellectual property rights related to the use of Propidium Monoazide for viability PCR.
The product is presented in a metallic zip bag with 2 screw cap dark glass vials containing each 0,5 mg of dry PMA: this format is easy to handle and has been specifically developed for viability PCR customers.
Thanks to the agreement with QIAGEN, GenIUL is now the first company that offers this licensed product specifically developed for viability PCR and our current price (ex works) of 80 euro for 1 mg (2x 0.5mg) is highly competitive and moreover also includes the non transferable license rights.
Date Published: September 24, 2012
Source article link: GENIUL, S.L. » company contact details
GC and CFU Correlation Of 9 Mycoplasma spp Examined With Sartorius' Microsart® Range
Why Bio-Rad? Learn More Here!
GNA Biosolutions Revealed New Ultrafast PCR Platform
iQ-Check® Free DNA Removal Solution for Legionella
Bio-Rad's Salmonella PCR Kit Receives AOAC OMA Approval